Advanced search
Publication Cover
Acta Oncologica Volume 51, 2012 - Issue 7
Journal homepage
1,570
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage

Tianhui ChenInstitute of Social and Family Medicine, School of Public Health, Zhejiang University, Hangzhou, China;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
,
Lina JansenDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
,
Adam GondosDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
,
Katharina EmrichCancer Registry of Rhineland-Palatinate, Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University Mainz, Germany
,
Bernd HolleczekSaarland Cancer Registry, Saarbrücken, Germany
,
Sabine LuttmannCancer Registry of Bremen, Bremen Institute for Prevention Research and Social Medicine, University of Bremen, Bremen, Germany
,
Annika WaldmannUniversity of Lübeck, Institute for Clinical Epidemiology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
,
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, GermanyCorrespondence[email protected]
& THE GEKID CANCER SURVIVAL WORKING GROUP* show all
Pages 915-921 | Received 14 Mar 2012, Accepted 25 Jun 2012, Published online: 29 Aug 2012

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jacob Christian Lindegaard, Lars Ulrik Fokdal, Søren Kynde Nielsen, Jens Juul-Christensen & Kari Tanderup. (2013) MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncologica 52:7, pages 1510-1519.
Read now

Articles from other publishers (26)

Yu-Fei Jiang, Yu Jiang, Jing-Hao Bi, Yun Zhang, Wen-Wei Zheng, Xiao-Hui Zhou, Jing Wu, Hui-Yun Yuan, Wen-Sui Zhao & Yong-Bing Xiang. (2023) Relative survival analysis of gynecological cancers in an urban district of Shanghai during 2002–2013. Cancer Epidemiology 84, pages 102355.
Crossref
Rui Ran, Xiaocui Zhong, Yang Yang, Xianglan Tang, Manlin Shi, Xingwei Jiang, Anping Lin, Xiaoling Gan, Tinghe Yu, Lina Hu, Xiaojing Dong & Ting-Li Han. (2023) Metabolomic profiling identifies hair as a robust biological sample for identifying women with cervical cancer. Medical Oncology 40:2.
Crossref
Avalon Sundqvist, Louise Moberg, Paul W. Dickman, Thomas Högberg & Christer Borgfeldt. (2022) Time Trends for Incidence and Net Survival of Cervical Cancer in Sweden 1960–2014—A Nationwide Population-Based Study. Cancer Epidemiology, Biomarkers & Prevention 31:8, pages 1572-1581.
Crossref
Hongsheng Lu, Lu Li, Yongran Cheng, Zhaohui Yang, Xuequan Cao, Hui Zhang, Dongju Qiao, Liangyou Wang & Tianhui Chen. (2022) Timely Estimates of 5-Year Relative Survival for Patients With Cervical Cancer: A Period Analysis Using Cancer Registry Data From Taizhou, Eastern China. Frontiers in Public Health 10.
Crossref
Hsiao-Wen Tsai, Chia-Jung Li, Li-Te Lin, An-Jen Chiang, San-Nung Chen, Zhi-Hong Wen & Kuan-Hao Tsui. (2022) Expression status and prognostic significance of mitochondrial dynamics OPA3 in human ovarian cancer. Aging 14:9, pages 3874-3886.
Crossref
Benyam Seifu, Chaltu Fikru, Delelegn Yilma & Fasil Tessema. (2022) Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis. PLOS ONE 17:2, pages e0264369.
Crossref
Manjulata Yadav, HS Kumar, Rajesh Kumar, Neeti Sharma & ShankarLal Jakhar. (2022) Survival pattern in cervical cancer patients in North West India: A tertiary care center study. Journal of Cancer Research and Therapeutics 18:6, pages 1530.
Crossref
Osvaldo Ulises Garay, Joaquín Maritano Furcada, Francisco Ayerbe, Ramiro A. Pena Requejo Rave & Silvio Alejandro Tatti. (2021) Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina. Value in Health Regional Issues 26, pages 160-168.
Crossref
Ionut Cobec, Ioan Sas, Aurica Moatar, Lavinia Moleriu & Andreas Rempen. (2021) Ovarian cancer health politics in Romania and Germany: A comparative study. Experimental and Therapeutic Medicine 22:5.
Crossref
Xiao-Qian Xu, Remila Rezhake, Shang-Ying Hu, Feng Chen, Xun Zhang, Qin-Jing Pan, Wen-Hua Zhang, Jun-Fei Ma, You-Lin Qiao, Fang-Hui Zhao & Margaret Cruickshank. (2021) Effect of Sequential Rounds of Cervical Cancer Screening on Management of HPV-positive Women: A 15-year Population-based Cohort Study from China. Cancer Prevention Research 14:3, pages 363-372.
Crossref
Alejandra Castanon, Daniela Tataru & Peter Sasieni. (2020) Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study. Cancers 12:8, pages 2079.
Crossref
Magdalena Bielska-Lasota, Silvia Rossi, Michalina Krzyżak, Annemie Haelens, Augius Domenic, Roberta De Angelis, Adam Maciejczyk, Miguel Rodríguez-Barranco, Vesna Zadnik & Pamela Minicozzi. (2019) Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Archives of Gynecology and Obstetrics 301:2, pages 591-602.
Crossref
Tanitra Tantitamit, Nipon Khemapech, Piyalamporn Havanond & Wichai Termrungruanglert. (2020) Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer. Cancer Control 27:1, pages 107327482092254.
Crossref
Peter Hillemanns & Matthias Jentschke. (2019) Leitlinienbasierte Strategie zur Prävention des Zervixkarzinoms. InFo Hämatologie + Onkologie 22:7-8, pages 42-49.
Crossref
Peter Hillemanns & Matthias Jentschke. (2019) Leitlinienbasierte Strategie zur Prävention des Zervixkarzinoms. gynäkologie + geburtshilfe 24:1, pages 34-41.
Crossref
Jonathan S. Berek, Koji Matsuo, Brendan H. Grubbs, David K. Gaffney, Susanna I. Lee, Aoife Kilcoyne, Gi Jeong Cheon, Chong Woo Yoo, Lu Li, Yifeng Shao, Tianhui Chen, Miseon Kim & Mikio Mikami. (2019) Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. Journal of Gynecologic Oncology 30:2.
Crossref
Wichai Termrungruanglert, Nipon Khemapech, Tanitra Tantitamit & Piyalamporn Havanond. (2019) Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology. Journal of Gynecologic Oncology 30:2.
Crossref
Elena Sophie Prigge, Magnus von Knebel Doeberitz & Miriam Reuschenbach. (2017) Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations. Mutation Research/Reviews in Mutation Research 772, pages 51-66.
Crossref
Murat Gultekin, Selin DundarIrem KucukyildizMujdegul Zayifoglu KaracaGuledal BoztasSemra Hatice TuranEzgi HacikamilogluBekir Keskinkilic. (2017) Survival of gynecological cancers in Turkey: where are we at?. Journal of Gynecologic Oncology 28:6.
Crossref
Jason D. Wright, Ling Chen, Ana I. Tergas, William M. Burke, June Y. Hou, Alfred I. Neugut, Cande V. Ananth & Dawn L. Hershman. (2015) Population-level trends in relative survival for cervical cancer. American Journal of Obstetrics and Gynecology 213:5, pages 670.e1-670.e7.
Crossref
Nor Asiah Muhamad, Muhammad Amir Kamaluddin, Mohd Yusoff Adon, Mohamed Asyraf Noh, Mohammed Faizal Bakhtiar, Nor Saleha Ibrahim Tamim, Siti Haniza Mahmud & Tahir Aris. (2015) Survival Rates of Cervical Cancer Patients in Malaysia. Asian Pacific Journal of Cancer Prevention 16:7, pages 3067-3072.
Crossref
Laurie Elit. (2014) Cervical cancer in the older woman. Maturitas 78:3, pages 160-167.
Crossref
Cem Onal, Mehmet Reyhan, Ozan C. Guler & Ali Fuat Yapar. (2014) Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy. European Journal of Nuclear Medicine and Molecular Imaging 41:7, pages 1336-1342.
Crossref
U. Seifert & S.J. Klug. (2014) Früherkennung des Zervixkarzinoms in DeutschlandEarly detection of cervical cancer in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 57:3, pages 294-301.
Crossref
Karl U. Petry, Bernhard Wörmann & Achim Schneider. (2014) Benefits and Risks of Cervical Cancer Screening. Oncology Research and Treatment 37:Suppl. 3, pages 48-57.
Crossref
M. Blettner & S. Ludwig. (2013) Epidemiologische Forschung mit den Daten der KrebsregisterEpidemiological research with data from cancer registries. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 57:1, pages 47-51.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.